Relapsed Angioimmunoblastic T-Cell Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed Angioimmunoblastic T-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL (NCT03593018) | The Lymphoma Academic Research Organisation | 2018-11-09 |
Track Relapsed Angioimmunoblastic T-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.